Impact of 0.5mg QD, 1mg QD and 1.0mg BID Alosetron Hydrochloride on Patient Satisfaction with IBS Treatment in Women with Chronic, Severe Diarrhea-Predominant IBS (D-IBS)

Authors :: Amy T Heath
Eric G. Carter
Marquita A. West
Vanessa Z. Ameen
Susan H. Gordon
Source :: American Journal of Gastroenterology. 101:S411-S412
Publication Year :: 2006
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2006.

Subjects :: Alosetron Hydrochloride
medicine.medical_specialty
Patient satisfaction
Hepatology
business.industry
Internal medicine
Gastroenterology
medicine
Severe diarrhea
business

Tools